EARNEST Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103M | Buy |
|
|||||
|
2025
Q1 | $91.9M | Buy |
|
|||||
|
2024
Q4 | $77.5M | Sell |
|
|||||
|
2024
Q3 | $93.1M | Sell |
|
|||||
|
2024
Q2 | $86.2M | Sell |
|
|||||
|
2024
Q1 | $80.8M | Buy |
|
|||||
|
2023
Q4 | $82.2M | Sell |
|
|||||
|
2023
Q3 | $83.1M | Sell |
|
|||||
|
2023
Q2 | $84.8M | Sell |
|
|||||
|
2023
Q1 | $78.3M | Sell |
|
|||||
|
2022
Q4 | $77.8M | Sell |
|
|||||
|
2022
Q3 | $66.3M | Buy |
|
|||||
|
2022
Q2 | $73.3M | Sell |
|
|||||
|
2022
Q1 | $78.4M | Sell |
|
|||||
|
2021
Q4 | $79.1M | Sell |
|
|||||
|
2021
Q3 | $77.1M | Sell |
|
|||||
|
2021
Q2 | $90.8M | Sell |
|
|||||
|
2021
Q1 | $91.7M | Buy |
|
|||||
|
2020
Q4 | $93.7M | Buy |
|
|||||
|
2020
Q3 | $84.5M | Sell |
|
|||||
|
2020
Q2 | $86.5M | Sell |
|
|||||
|
2020
Q1 | $110M | Sell |
|
|||||
|
2019
Q4 | $180M | Sell |
|
|||||
|
2019
Q3 | $169M | Buy |
|
|||||
|
2019
Q2 | $176M | Sell |
|
|||||
|
2019
Q1 | $187M | Buy |
|
|||||
|
2018
Q4 | $165M | Sell |
|
|||||
|
2018
Q3 | $168M | Sell |
|
|||||
|
2018
Q2 | $149M | Buy |
|
|||||
|
2018
Q1 | $159M | Sell |
|
|||||
|
2017
Q4 | $168M | Sell |
|
|||||
|
2017
Q3 | $172M | Sell |
|
|||||
|
2017
Q2 | $171M | Sell |
|
|||||
|
2017
Q1 | $154M | Sell |
|
|||||
|
2016
Q4 | $152M | Buy |
|
|||||
|
2016
Q3 | $142M | Sell |
|
|||||
|
2016
Q2 | $154M | Sell |
|
|||||
|
2016
Q1 | $153M | Sell |
|
|||||
|
2015
Q4 | $186M | Sell |
|
|||||
|
2015
Q3 | $205M | Buy |
|
|||||
|
2015
Q2 | $219M | Buy |
|
|||||
|
2015
Q1 | $214M | Sell |
|
|||||
|
2014
Q4 | $209M | Buy |
|
|||||
|
2014
Q3 | $208M | Sell |
|
|||||
|
2014
Q2 | $212M | Sell |
|
|||||
|
2014
Q1 | $202M | Buy |
|
|||||
|
2013
Q4 | $185M | Buy |
|